NCT05769348View on ClinicalTrials.gov

Investigation and Modulation of the Central Mu-Opioid Mechanism in Migraine (in Vivo)

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 26, 2023

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
Chronic Migraine
Interventions
DEVICE

HD-tDCS Active Protocol

non-invasive brain stimulation (active protocol)

DEVICE

HD-tDCS Sham Protocol

non-invasive brain stimulation (sham protocol)

Trial Locations (1)

48109

RECRUITING

University of Michigan, Ann Arbor

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

University of Michigan

OTHER